We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
-2.49%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$12.8B
AUM Growth
-$896M
Cap. Flow
-$396M
Cap. Flow %
-3.08%
Top 10 Hldgs %
24.99%
Holding
3,035
New
97
Increased
329
Reduced
999
Closed
146

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$37.9M
2
BX icon
Blackstone
BX
+$16.9M
3
ABNB icon
Airbnb
ABNB
+$13.4M
4
KVUE icon
Kenvue
KVUE
+$10.4M
5
CIVI
Civitas Resources
CIVI
+$7.3M

Top Sells

Rank Stock Value
1
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$125M
2
ACN icon
Accenture
ACN
+$57.6M
3
MDT icon
Medtronic
MDT
+$28M
4
AAPL icon
Apple
AAPL
+$21.2M
5
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$19.3M

Sector Composition

Rank Sector Weight
1 Technology 25.12%
2 Healthcare 12.03%
3 Financials 11.49%
4 Consumer Discretionary 10.97%
5 Industrials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XAIR icon
2926
Beyond Air
XAIR
$5.37M
– –
-34
Closed -$58.3K
XPRO icon
2927
Expro Ltd
XPRO
$2.07B
– –
-46,907
Closed -$831K
MAGN
2928
Magnera Corp
MAGN
$443M
– –
-1,812
Closed -$71.1K
WHWK
2929
Whitehawk Therapeutics
WHWK
$269M
– –
-8,693
Closed -$59.5K
TVRD
2930
Tvardi Therapeutics
TVRD
$22.1M
– –
-560
Closed -$57K
VOXX
2931
DELISTED
VOXX International Corporation Class A
VOXX
– –
-7,444
Closed -$92.9K
OMGA
2932
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
– –
-13,737
Closed -$76.9K
AKTS
2933
DELISTED
Akoustis Technologies Inc
AKTS
– –
-39,725
Closed -$126K
BHIL
2934
DELISTED
Benson Hill, Inc.
BHIL
– –
-2,731
Closed -$124K
TARO
2935
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
– –
-4,336
Closed -$164K
NGM
2936
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
– –
-21,464
Closed -$55.6K
CRGE
2937
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
– –
-68,934
Closed -$67.6K
THRX
2938
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
– –
-10,330
Closed -$96.4K
NSTG
2939
DELISTED
NanoString Technologies, Inc.
NSTG
– –
-24,478
Closed -$99.1K
NETI
2940
DELISTED
Eneti Inc.
NETI
– –
-12,718
Closed -$154K
CANO
2941
DELISTED
Cano Health, Inc.
CANO
– –
-1,304
Closed -$181K
TRTN
2942
DELISTED
Triton International Limited
TRTN
– –
-28,783
Closed -$2.4M
SYNH
2943
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
– –
-62,110
Closed -$2.62M
RETA
2944
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-15,065
Closed -$1.54M
RADI
2945
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
– –
-45,167
Closed -$673K
WWE
2946
DELISTED
World Wrestling Entertainment
WWE
– –
-27,798
Closed -$3.02M
RTL
2947
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
– –
-72,200
Closed -$488K
QUOT
2948
DELISTED
Quotient Technology Inc
QUOT
– –
-48,605
Closed -$187K
BKI
2949
DELISTED
Black Knight, Inc. Common Stock
BKI
– –
-3,070
Closed -$183K
NEX
2950
DELISTED
NexTier Oilfield Solutions Inc.
NEX
– –
-102,661
Closed -$918K
115 116 117
118
119

Similar funds

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

MetLife Investment Management's Q3 2023 Portfolio in Review

As of Q3 2023, MetLife Investment Management held 3,035 positions worth $12.8B, down 6.5% from $13.7B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management withdrew a net $396M in Q3 2023, closing 146 positions and reducing 999 holdings. Its most notable exit was Accenture, an estimated $57.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

Against the trend, MetLife Investment Management opened a new position in Kenvue worth $9.06M.

  • MetLife Investment Management's largest Q3 2023 buy was Kenvue: 451,001 shares worth $9.06M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $37.9M increase.
  • MetLife Investment Management's biggest Q3 2023 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $125M.
  • MetLife Investment Management fully exited Accenture in Q3 2023, selling an estimated $57.6M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $12.8B portfolio in Q3 2023.
  • MetLife Investment Management opened 97 new positions and closed 146 in Q3 2023.
  • MetLife Investment Management's portfolio value fell 6.5% quarter-over-quarter to $12.8B.

Based on MetLife Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.